Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    If you like AstraZeneca, you could love this health-focused small-cap

    | Kevin Godbold

    As well as AstraZeneca plc (LON: AZN), this small-cap has decent potential for accelerating growth down the line. I see…

    Read more »

    Investing Articles

    2 FTSE 100 dividend stocks I’d buy for my ISA

    | Rupert Hargreaves

    Defensive business models and rapidly growing earnings make these two FTSE 100 (INDEXFTSE: UKX) stocks perfect ISA buys to Rupert…

    Read more »

    Investing Articles

    Retirement saving: I think AstraZeneca could help you to accumulate £1 million

    | Peter Stephens

    AstraZeneca plc (LON: AZN) may offer a mix of income and growth potential which could boost your retirement prospects in…

    Read more »

    Investing Articles

    2 FTSE 100 shares to buy for the next 10 years that I think could make you richer

    | Andy Ross

    Andy Ross explains why he thinks these two FTSE 100 (INDEXFTSE:UKX) companies are great picks to hold for the next…

    Read more »

    Investing Articles

    Here’s why the AstraZeneca share price is flying today

    | Paul Summers

    Shares in pharma giant AstraZeneca plc (LON:AZN) jumped on encouraging full-year results. Should new investors be tempted to buy?

    Read more »

    Investing Articles

    Have £1k to invest? Here’s one FTSE 100 stock I’d buy before anything else

    | Rupert Hargreaves

    Rupert Hargreaves runs his eye over a FTSE 100 (INDEXFTSE: UKX) income hero with a bright future.

    Read more »

    Investing Articles

    Why I’d avoid the AstraZeneca share price and buy this FTSE 250 dividend stock

    | Roland Head

    AstraZeneca plc (LON:AZN) could leave your portfolio feeling poorly, says Roland Head, who suggests an opportunity in the FTSE 250…

    Read more »

    Investing Articles

    Why I think the AstraZeneca share price could crush the FTSE 100 this year

    | Peter Stephens

    AstraZeneca plc (LON: AZN) appears to offer better value for money than the FTSE 100.

    Read more »

    Investing Articles

    Will AstraZeneca continue to outperform in 2019?

    | Andy Ross

    Andy Ross sees plenty to be upbeat about at AstraZeneca plc (LON:AZN) that he thinks could keep it beating the…

    Read more »

    Investing Articles

    Why I’d pick the GSK and AstraZeneca share prices to beat my State Pension

    | Alan Oscroft

    I'm looking to re-invest a company pension, and here's why AstraZeneca plc (LON: AZN) and GlaxoSmithKline plc (LON: GSK) shares…

    Read more »

    Investing Articles

    The AstraZeneca and GSK share prices look like buys to me as the FTSE 100 crashes

    | Harvey Jones

    Harvey Jones says AstraZeneca plc (LON: AZN) and GlaxoSmithKline plc (LON: GSK) have the antidote to the current FTSE 100…

    Read more »

    Investing Articles

    I think this FTSE 100 dividend stock could be poised for big gains in 2019

    | Royston Wild

    Royston Wild identifies a FTSE 100 (INDEXFTSE: UKX) income hero that could sprint still higher in 2019.

    Read more »